AO
Aspen Oss B.V. (Aspen API)
CDMO · Oss, Netherlands
GMP
Overview
Aspen Oss traces its origins to 1923 and, after the Organon, Schering-Plough and MSD years, joined the Aspen Group in 2013. Its Moleneind site in Oss performs peptide, biochemical and small-scale chemical manufacturing, and Aspen API also offers development and manufacturing services. It holds active US Type II DMFs for Desmopressin, Ganirelix, Gonadorelin, Oxytocin. Aspen lists inspection approvals for the Oss site from US FDA, PMDA, ANVISA, KFDA and the Dutch authority.
Capabilities
- Liquid-phase peptide synthesis
- Peptide API manufacturing
- Steroid hormone and HPAPI production
- Development and manufacturing services
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |